A reverse transfection technology to genetically engineer adult stem cells

被引:57
作者
Okazaki, Arimichi [1 ]
Jo, Jun-Ichiro [1 ]
Tabata, Yasuhiko [1 ]
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Field Tissue Engn, Dept Biomat,Sakyo Ku, Kyoto 6068507, Japan
来源
TISSUE ENGINEERING | 2007年 / 13卷 / 02期
关键词
D O I
10.1089/ten.2006.0185
中图分类号
Q813 [细胞工程];
学科分类号
摘要
A new non-viral method of gene transfection was designed to enhance the level of gene expression for rat mesenchymal stem cells (MSCs). Pullulan was cationized using chemical introduction of spermine to prepare cationized pullulan of non-viral carrier (spermine-pullulan). The spermine-pullulan was complexed with a plasmid deoxyribonucleic acid (DNA) of luciferase and coated on the surface of culture substrate together with Pronectin of artificial cell adhesion protein. MSCs were cultured and transfected on the complex-coated substrate (reverse transfection), and the level and duration of gene expression were compared with those of MSCs transfected by culturing in the medium containing the plasmid DNA-spermine-pullulan complex (conventional method). The reverse transfection method enhanced and prolonged gene expression significantly more than did the conventional method. The reverse method permitted the transfection culture of MSCs in the presence of serum, in contrast to the conventional method, which gave cells a good culture condition to lower cytotoxicity. The reverse transfection was carried out for a non-woven fabric of polyethylene terephthalate (PET) coated with the complex and Pronectin using agitation and stirring culture methods. The two methods enhanced the level and duration of gene expression for MSCs significantly more than did the static method. It is possible that medium circulation improves the culture conditions of cells in terms of oxygen and nutrition supply and waste excretion, resulting in enhanced gene expression.
引用
收藏
页码:245 / 251
页数:7
相关论文
共 44 条
[1]   Lectin-mediated drug targeting: history and applications [J].
Bies, C ;
Lehr, CM ;
Woodley, JF .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (04) :425-435
[2]   Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery [J].
Blessing, T ;
Kursa, M ;
Holzhauser, R ;
Kircheis, R ;
Wagner, E .
BIOCONJUGATE CHEMISTRY, 2001, 12 (04) :529-537
[3]   Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration [J].
Chang, SCN ;
Chuang, HL ;
Chen, YR ;
Chen, JK ;
Chung, HY ;
Lu, YL ;
Lin, HY ;
Tai, CL ;
Lou, J .
GENE THERAPY, 2003, 10 (24) :2013-2019
[4]   Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly (L-lysine) conjugate [J].
Cho, KC ;
Kim, SH ;
Jeong, JH ;
Park, TG .
MACROMOLECULAR BIOSCIENCE, 2005, 5 (06) :512-519
[5]   Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine, and its complex with plasmid DNA [J].
Choi, YH ;
Liu, F ;
Choi, JS ;
Kim, SW ;
Park, JS .
HUMAN GENE THERAPY, 1999, 10 (16) :2657-2665
[6]  
CHOWDHURY NR, 1993, J BIOL CHEM, V268, P11265
[7]   Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells [J].
Colin, M ;
Maurice, M ;
Trugnan, G ;
Kornprobst, M ;
Harbottle, RP ;
Knight, A ;
Cooper, RG ;
Miller, AD ;
Capeau, J ;
Coutelle, C ;
Brahimi-Horn, MC .
GENE THERAPY, 2000, 7 (02) :139-152
[8]   Cationic liposomes for gene delivery:: From biophysics to biological applications [J].
de Lima, MCP ;
Neves, S ;
Filipe, A ;
Düzgünes, N ;
Simoes, S .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (14) :1221-1231
[9]   Cationic polymer based gene delivery systems [J].
De Smedt, SC ;
Demeester, J ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :113-126
[10]   Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway [J].
Erbacher, P ;
Remy, JS ;
Behr, JP .
GENE THERAPY, 1999, 6 (01) :138-145